It is a chemicals public limited company based in New Delhi, Delhi, India, established in 2012.
2012 | New Delhi, Delhi, India | Struck OffDdm Pharmaceuticals Limited, a struck off public limited company, was established on 30 August 2012 in New Delhi, Delhi, India. Engaging in basic chemical within the chemicals sector, it holds CIN: U24110DL2012PLC241405. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
Its leadership includes Desiree Anwar Nagpal (Director), Dennis Nagpal (Director), Maxwel Nagpal (Director). Past directors included Akshit Kumar. Its latest AGM occurred on 22 September 2014, with the balance sheet filed on 31 March 2013. It is based at Flat.No.302/72 Laxmi Bhawan, Nehru Palace,, New Delhi, Delhi, 110003.
U24110DL2012PLC241405
241405
30 August 2012
₹0.50 M
₹0.50 M
Roc Delhi
Unlisted
Struck Off
Explore comprehensive insights into Ddm Pharmaceuticals Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Desiree Anwar Nagpal | Director | 10 Jul 2013 | Current |
| Dennis Nagpal | Director | 30 Aug 2012 | Current |
| Maxwel Nagpal | Director | 30 Aug 2012 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 05 Jul 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Enhance accessibility to Ddm Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
Unlock access to Ddm Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ddm Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ddm Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ddm Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ddm Pharmaceuticals Limited last Annual general meeting of members was held on 22 Sep 2014 as per latest MCA records. was recorded as a recent event.
Desiree Anwar Nagpal was appointed as a Director was appointed as a Director on 10 Jul 2013 & has been associated with this company since 12 years 5 months . was recorded as a recent event.
Progress on Ddm Pharmaceuticals Limited has filed its annual Financial statements for the year ended 31 Mar 2013 with Roc Delhi. was documented.
Progress on Dennis Nagpal was appointed as a Director was appointed as a Director on 30 Aug 2012 & has been associated with this company since 13 years 3 months . was documented.
The activity Maxwel Nagpal was appointed as a Director was appointed as a Director on 30 Aug 2012 & has been associated with this company since 13 years 3 months . was completed.
The activity Ddm Pharmaceuticals Limited was registered on 30 Aug 2012 with Roc Delhi & aged 13 years 3 months as per MCA records. was completed.
The CIN of Ddm Pharmaceuticals Limited is U24110DL2012PLC241405.
Ddm Pharmaceuticals Limited is headquartered at Flat.No.302/72 Laxmi Bhawan, Nehru Palace,, New Delhi, Delhi, 110003.
Ddm Pharmaceuticals Limited was incorporated on 30 August 2012.
The current directors of Ddm Pharmaceuticals Limited are
The primary industry of Ddm Pharmaceuticals Limited is Chemicals.
Ddm Pharmaceuticals Limited is unlisted.
The authorized capital of Ddm Pharmaceuticals Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX